1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           South & Central America Vaccine Adjuvants Market – Key Market Dynamics

4.1       South & Central America Vaccine Adjuvants Market – Key Market Dynamics

4.2       Market Drivers

4.2.1         Rising Number of Infectious Disease Outbreaks and Pandemic

4.2.2         Approvals of Veterinary Vaccine Adjuvants

4.3       Market Restraints

4.3.1         Product Recalls and Adverse Effects

4.4       Market Opportunity

4.4.1         Advancements in Biotechnology and Immunology

4.5       Future Trends

4.5.1         Technological Advancements

4.6       Impact of Drivers and Restraints:

5.           Vaccine Adjuvants Market –South & Central America Market Analysis

5.1       South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

5.2       South & Central America Vaccine Adjuvants Market Forecast and Analysis

6.           South & Central America Vaccine Adjuvants Market Analysis – by Adjuvant Class

6.1       Overview

6.2       Mineral Salt Adjuvant

6.2.1         Overview

6.2.2         Mineral Salt Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

6.3       Emulsion Adjuvant

6.3.1         Overview

6.3.2         Emulsion Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

6.4       Liposome Adjuvant

6.4.1         Overview

6.4.2         Liposome Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

6.5       Others

6.5.1         Overview

6.5.2         Others: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7.           South & Central America Vaccine Adjuvants Market Analysis – by Type

7.1       Human Vaccine Adjuvant

7.1.1         Overview

7.1.2         Human Vaccine Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7.2       Veterinary Vaccine Adjuvant

7.2.1         Overview

7.2.2         Veterinary Vaccine Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.           South and Central America Vaccine Adjuvants Market –Country Analysis

8.1       South & Central America

8.1.1         South and Central America Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country

8.1.1.1            Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.1           Overview

8.1.1.1.2           Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.3           Brazil: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.1.4           Brazil: Vaccine Adjuvants Market Breakdown by Type

8.1.1.2            Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.1           Overview

8.1.1.2.2           Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.3           Argentina: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.2.4           Argentina: Vaccine Adjuvants Market Breakdown, by Type

8.1.1.3            Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.1           Overview

8.1.1.3.2           Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.3           Rest of South and Central America Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.3.4           Rest of South and Central America Vaccine Adjuvants Market Breakdown, by Type

9.           Industry Landscape

9.1       Overview

9.2       Growth Strategies in the Vaccine Adjuvants Market

9.3       Organic Developments

9.3.1         Overview

9.4       Inorganic Developments

9.4.1         Overview

10.        Company Profiles

10.1     GSK Plc

10.1.1       Key Facts

10.1.2       Business Description

10.1.3       Products and Services

10.1.4       Financial Overview

10.1.5       SWOT Analysis

10.1.6       Key Developments

10.2     CSL Ltd

10.2.1       Key Facts

10.2.2       Business Description

10.2.3       Products and Services

10.2.4       Financial Overview

10.2.5       SWOT Analysis

10.2.6       Key Developments

10.3     Croda International Plc

10.3.1       Key Facts

10.3.2       Business Description

10.3.3       Products and Services

10.3.4       Financial Overview

10.3.5       SWOT Analysis

10.3.6       Key Developments

10.4     Novavax Inc

10.4.1       Key Facts

10.4.2       Business Description

10.4.3       Products and Services

10.4.4       Financial Overview

10.4.5       SWOT Analysis

10.4.6       Key Developments

10.5     Phibro Animal Health Corp

10.5.1       Key Facts

10.5.2       Business Description

10.5.3       Products and Services

10.5.4       Financial Overview

10.5.5       SWOT Analysis

10.5.6       Key Developments

11.        Appendix

11.1     About The Insight Partners

List of Tables

Table 1.             South & Central America Vaccine Adjuvants Market Segmentation

Table 2.             South & Central America Vaccine Adjuvants Market Revenue and Forecasts To 2030 (US$ Million)

Table 3.             Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 4.             Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 5.             Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 6.             Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 7.             Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 8.             Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 9.             Organic Developments Done by Companies

Table 10.          Inorganic Developments Done by Companies

List of Figures

Figure 1.           South & Central America Vaccine Adjuvants Market Segmentation, by Country

Figure 2.           Impact Analysis of Drivers and Restraints

Figure 3.           South & Central America Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030

Figure 4.           South & Central America Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)

Figure 5.           Mineral Salt Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 6.           Emulsion Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.           Liposome Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Others: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           South & Central America Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)

Figure 10.        Human Vaccine Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        Veterinary Vaccine Adjuvant: South & Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        South and Central America Vaccine Adjuvants Market by Key Countries – Revenue 2022 (US$ Million)

Figure 13.        South and Central America Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 14.        Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 15.        Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 16.        Rest of South and Central America Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 17.        Growth Strategies in the Vaccine Adjuvants Market